FR2868309B1 - COSMETIC USE OF AT LEAST ONE HMG-COA-REDUCTASE INHIBITOR AS AN AGENT FOR PREVENTING AND / OR COMBATTING EXPRESSION WRINKLES - Google Patents

COSMETIC USE OF AT LEAST ONE HMG-COA-REDUCTASE INHIBITOR AS AN AGENT FOR PREVENTING AND / OR COMBATTING EXPRESSION WRINKLES

Info

Publication number
FR2868309B1
FR2868309B1 FR0450653A FR0450653A FR2868309B1 FR 2868309 B1 FR2868309 B1 FR 2868309B1 FR 0450653 A FR0450653 A FR 0450653A FR 0450653 A FR0450653 A FR 0450653A FR 2868309 B1 FR2868309 B1 FR 2868309B1
Authority
FR
France
Prior art keywords
combatting
hmg
coa
preventing
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0450653A
Other languages
French (fr)
Other versions
FR2868309A1 (en
Inventor
Dominique Fagot
Pascal Portes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0450653A priority Critical patent/FR2868309B1/en
Publication of FR2868309A1 publication Critical patent/FR2868309A1/en
Application granted granted Critical
Publication of FR2868309B1 publication Critical patent/FR2868309B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
FR0450653A 2004-04-02 2004-04-02 COSMETIC USE OF AT LEAST ONE HMG-COA-REDUCTASE INHIBITOR AS AN AGENT FOR PREVENTING AND / OR COMBATTING EXPRESSION WRINKLES Expired - Lifetime FR2868309B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0450653A FR2868309B1 (en) 2004-04-02 2004-04-02 COSMETIC USE OF AT LEAST ONE HMG-COA-REDUCTASE INHIBITOR AS AN AGENT FOR PREVENTING AND / OR COMBATTING EXPRESSION WRINKLES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0450653A FR2868309B1 (en) 2004-04-02 2004-04-02 COSMETIC USE OF AT LEAST ONE HMG-COA-REDUCTASE INHIBITOR AS AN AGENT FOR PREVENTING AND / OR COMBATTING EXPRESSION WRINKLES

Publications (2)

Publication Number Publication Date
FR2868309A1 FR2868309A1 (en) 2005-10-07
FR2868309B1 true FR2868309B1 (en) 2006-05-26

Family

ID=34944360

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0450653A Expired - Lifetime FR2868309B1 (en) 2004-04-02 2004-04-02 COSMETIC USE OF AT LEAST ONE HMG-COA-REDUCTASE INHIBITOR AS AN AGENT FOR PREVENTING AND / OR COMBATTING EXPRESSION WRINKLES

Country Status (1)

Country Link
FR (1) FR2868309B1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940125B1 (en) * 2008-12-23 2013-03-22 Isp Investments Inc COSMETIC OR PHARMACEUTICAL SOOTHING COMPOSITION COMPRISING AN ACTIVATOR PEPTIDE OF HMG-COA REDUCTASE
FR2940126B1 (en) 2008-12-23 2013-05-10 Isp Investments Inc COSMETIC OR PHARMACEUTICAL SOOTHING COMPOSITION COMPRISING AN ACTIVATOR PEPTIDE OF HMG-COA REDUCTASE
FR2940292B1 (en) 2008-12-23 2013-05-10 Isp Investments Inc PEPTIDES DERIVED FROM HMG-COA REDUCTASE AND COSMETIC AND / OR PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2940291B1 (en) * 2008-12-23 2012-12-21 Isp Investments Inc PEPTIDE DERIVED FROM HMG-COA REDUCTASE AND COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
FR2944526B1 (en) 2009-04-15 2013-05-10 Isp Investments Inc COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING A PEPTIDE HYDROLYZATE CAPABLE OF STRENGTHENING BARRIER FUNCTION
FR2944445B1 (en) 2009-04-15 2013-08-16 Isp Investments Inc COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING A SOOTHING PEPTIDE HYDROLYZATE
US8933036B2 (en) 2009-04-15 2015-01-13 Isp Investments Inc. Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0738510A3 (en) * 1995-04-20 2005-12-21 L'oreal Use of a HMG-CoA reductase inhibitor as an anti-ageing agent and as an anti-acne agent. Composition comprising at least one HMG-CoA reductase inhibitor and at least one active substance with scaling properties.
US5902805A (en) * 1996-04-22 1999-05-11 L'oreal Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same
FR2798590B1 (en) * 1999-09-21 2001-11-30 Oreal USE OF ALVERINE TO REDUCE WRINKLES
FR2799649B1 (en) * 1999-10-13 2005-05-20 Oreal COMPOSITION, PARTICULARLY COSMETIC, CONTAINING DHEA AND A DESQUAMANT AGENT
FR2801508B1 (en) * 1999-11-29 2003-11-14 Oreal USE OF HMG COA-REDUCTASE INHIBITORS FOR THE TREATMENT OF SEBORRHEA
FR2809005B1 (en) * 2000-05-18 2002-12-27 Oreal USE OF MANGANESE IN THE TREATMENT OF WRINKLES
FR2838344B1 (en) * 2002-04-12 2005-06-17 Oreal USE OF A SAPOGENINE, OR A NATURAL EXTRACT CONTAINING, TO ENHANCE THE RIDES AND RIDULES OF EXPRESSION

Also Published As

Publication number Publication date
FR2868309A1 (en) 2005-10-07

Similar Documents

Publication Publication Date Title
ZA200501677B (en) Hydantoin derivatives and their use as TACE inhibitors.
FR12C0019I1 (en) O-CYCLOPROPYL-CARBOXANILIDES AND THEIR USE AS FUNGICIDES
HK1089167A1 (en) 2-pyridone derivatives as netrophil elastase inhibitors and their use 2-
HK1208865A1 (en) Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors 6 pde4
ATE302193T1 (en) BENZOHETEROCYCLES AND THEIR USE AS MEK INHIBITORS
DE602004028079D1 (en) Cosmetic aerosol composition
HK1065259A1 (en) Water-in-oil emulsion cosmetic composition
AU2003232848A8 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
EP1535514A4 (en) Composition for protecting organ, tissue or cell and utilization thereof
ATE382040T1 (en) ACYLAMINOTHIAZOLE DERIVATIVES AND THEIR USE AS BETA-AMYLOID INHIBITORS
FR2868309B1 (en) COSMETIC USE OF AT LEAST ONE HMG-COA-REDUCTASE INHIBITOR AS AN AGENT FOR PREVENTING AND / OR COMBATTING EXPRESSION WRINKLES
ATE308323T1 (en) DIAMINOTHIAZOLES AND THEIR USE AS CDK4 INHIBITORS
PL371217A1 (en) Inhibitors of integrin alphavbeta6
EP1708677A4 (en) Cosmetic composition containing a protein and an enzyme inhibitor
PL1762219T3 (en) Photoprotective and/or photoimmunoprotective compositions for the skin and uses thereof
WO2004026295A3 (en) Use of skin-protecting substances
FR2894824B1 (en) USE OF TRYPTOPHAN AND / OR 5-HYDROXYTRYPTOPHANE, OR A VEGETABLE EXTRACT CONTAINING AS A COSMETIC AGENT
AU2003211520A1 (en) Lfa-1 inhibitors and use thereof
AU2003259076A1 (en) Absorbent product moisturizing and lubricating composition
SI1532141T1 (en) 2-PYRROLIDIN-2-YL- ?á1,3,4?å-OXADIAZOLE DERIVATIVES AND THE USE OF THE SAME AS ANTIDEPRESSANTS
EP1473302A4 (en) Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
AU2003277640A8 (en) Composition for restoring damaged skin
EP1572931A3 (en) Methods and compositions for modulating and detecting wisp activity
FR2886544B1 (en) COSMETIC USE OF ESSENTIAL OILS
AU2003299507A8 (en) Hop - a novel cardiac-restricted transcriptional factor potentially useful for cardiac regeneration and specification